{"type":"rich","version":"1.0","title":"Remdesivir Needs More Trials Before Going All In: MMKCC's Bach","author_name":"Bloomberg Intelligence","author_url":"https://bloomberg.com/podcasts/taking_stock","provider_name":"Omny Studio","provider_url":"https://omny.fm","html":"<iframe src=\"https://omny.fm/shows/the-tape/remdesivir-needs-more-trials-before-going-all-in-m/embed\" width=\"100%\" height=\"180\" allow=\"autoplay; clipboard-write; fullscreen\" allowfullscreen frameborder=\"0\" title=\"Remdesivir Needs More Trials Before Going All In: MMKCC's Bach\"></iframe>","width":600,"height":180}